Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
2021 ◽
Vol 104
(Suppl. 3)
◽
pp. 65-71
2002 ◽
Vol 17
(5)
◽
pp. 355-358
◽
Keyword(s):
2015 ◽
Vol 18
(1)
◽
pp. 100-103
◽
Keyword(s):
2007 ◽
Vol 19
(1)
◽
pp. 51-58
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 13
◽
pp. S47
◽
Keyword(s):